How to Quickly Dissolve Corrosion Inhibitors
So, is there a way to dissolve the corrosion inhibitor used as a thickener quickly?
1. Choose powder scale inhibitor ATMP
IRO 95% ATMP |
The scale inhibition inhibitor, the smaller the particle size of the corrosion inhibitor, the shorter the dissolution time. The powder scale inhibitor and the particle scale inhibitor have the same viscosity, molecular weight, and performance index.
2. Keep the water temperature between 20-30 degrees Celsius
The stability of the scale inhibitor is very good. Usually, between 3-40 degrees Celsius, the performance of the scale inhibitor will not change. We all know that the higher the water temperature, the greater the intermolecular activity and the faster the object dissolves.Therefore, on the one hand, in order to prevent the safety of the scale inhibitor, on the other hand, in order to dissolve the corrosion inhibitor more quickly, we recommend that when the scale inhibitor is dissolved.
The water temperature should be within 20-30 °C, when the scale inhibitor dissolves. When it is safe and effective.
A scale inhibitor refers to a salt that forms a chemical substance that inhibits scales such as calcium and magnesium from entering scales.
Inorganic inhibitors such as sodium hexametaphosphate, sodium tripolyphosphate, and the like. Organic inhibitors such as polymer scale inhibitors. Among them, the best effect of polymer scale inhibitor has great development prospects.
There are two types of organic and macromolecular scale inhibitors used in water treatment.
Organic phosphonic acid, such as ATMP, EDTMP, HEDP. Polycarboxylic acids such as PAA(S), HPMA, and the like.
The scale inhibition of these two scale inhibitors is usually achieved by lattice distortion and dispersion-condensation and is widely used in oilfield water, boiler water, and industrial cooling water systems.
For more information, please visit our website at www.iroatmp.com.
Degrasyn, also known as WP1130, is a small molecule that specifically and rapidly down-regulates both wild-type and mutant Bcr/Abl protein without affecting bcr/abl gene expression in chronic myelogenous leukemia (CML) cells and Hsp90/Hsp70 ratios within the cells. Degrasyn
ReplyDelete